The Food and Drug Administration (FDA) has withdrawn studies that suggested COVID-19 and shingles vaccines were safe and ...
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...
FDA officials stopped publication of studies backing COVID-19 and shingles vaccine safety, citing data concerns.
In the latest update to COVID and vaccine-related discourse bubbling up at the FDA, agency officials have recently blocked ...
A CDC-based vaccine advisory panel — comprised mostly of vaccine skeptics appointed by Robert F. Kennedy Jr. last year — also ...
The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to ...
Combriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains ...
A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled "Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of ...
The closed sites include some that came with its $1.25 billion takeover of CureVac last year, and BioNTech has said it hopes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results